Sanifit
is a Spain-based biopharmaceutical company that develops and commercializes small molecule therapeutics for the treatment of vascular calcification disorders... Read moreSanifit
is a Spain-based biopharmaceutical company that develops and commercializes small molecule therapeutics for the treatment of vascular calcification disorders... Read more
News
Jan 28, 2022
LaingBuisson
Sanifit: InConversation: HMi meets Pablo Cironi, Director of Life Science Investment Funds at Caixa Capital Risc
Nov 26, 2021
FinSMEs
Sanifit: Vifor Pharma Acquires Sanifit Therapeutics
Nov 23, 2021
LaingBuisson
Sanifit: Spain: Vifor Pharma to acquire Sanifit for upfront 205m to further strengthen late-stage pipeline in nephrology
Nov 23, 2021
European Biotechnology
Sanifit: Vifor buys out one-drug wonder Sanifit
Nov 22, 2021
Benzinga
Sanifit: Vifor Pharma Bolsters Its Presence In Vascular Calcification Field Via Two Acquisition Deals
Nov 22, 2021
MedCity News
Sanifit: Vifor Pharma adds to chronic kidney disease lineup with pair of acquisitions
Feb 10, 2021
GlobalNewswire
Press Release: Sanifit : Sanifit Granted Orphan Drug Designation by the FDA for SNF472 for the Treatment of Peripheral Arterial Disease in Patients with End-stage Kidney Disease
Jul 20, 2020
GlobalNewswire
Press Release: Sanifit : Sanifit to start new clinical development program of SNF472 in End Stage Kidney Disease patients with Peripheral Artery Disease
Feb 13, 2020
MarketScreener
Sanifit: First patient dosed in pivotal phase 3 trial of SNF472 in calciphylaxis
Nov 12, 2019
FE Investegate
Sanifit: Laboratoris Sanifit S.L. : Positive data from Sanifit's Phase 2b CaLIPSO trial of SNF472 published in Circulation
Sanifit Competitors
1
2
3
4
5
6
7
8
9
10